Tamar Fisher, PhD
Email: tamar.fisher@sheba.health.gov.il
Phone: Israel 03-5303615, International +972-3-530-3615
Position
Senior Researcher and Laboratory Manager of Pediatric Leukemia's, Solid and Brain Tumor Research Laboratory – the "Pediatric Hemato-Oncology Research Lab"
Areas of Expertise
Dr. Fisher’s pioneer studies focus on anti-tumoral molecular mechanisms of "new old drugs" such as Cannabinoids (THC and CBD) on glioblastoma and leukemia's cell lines, primary cells and neuroblastoma cell lines. She researched the molecular characterization of stem cells from various sources: bone marrow, cord blood, peripheral blood and fetal liver.
Dr. Fisher’s current focus is on the anti tumoral molecular mechanisms of Cannabinoids and Cannabinoids-Like with regard to pediatric tumor cell lines especially Neuroblastomas (NB), primary cells and tumors induced in NOD-SCID mice or NUD mice (xenografts). Dr. Fisher also guides rotating physicians, PhD and M.Sc. students in their first steps in the scientific work in the lab.
In Dr. Fisher’s early work, she used phylogenetic analysis using molecular tools at the Laboratory of Ecology and Physiology of Invertebrates, Faculty of Life Sciences, Bar-Ilan University.
Dr. Fisher is extremely involved, supporting and assisting with a variety of laboratory research projects. Dr. Fisher attended courses of "Management Clinical Research" (GCP) and "Biological and Chemical Safety in the Laboratory" at the Israeli Institute of Occupational Safety and Hygiene.
Education
MSc, with honors, Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
PhD, Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
Award
Dean's Scholarship of Distinction (for Ph.D. students), Faculty of Natural Sciences and Mathematics, Bar-Ilan University (Awarded twice)
Affiliations
Pediatric Hemato-Oncology Research Laboratory, Sheba Medical Center, Tel Hashomer, Israel
Cancer Research Institute, Sheba Medical Center, Tel Hashomer, Israel
Research Interests
The effectiveness and the anti-tumorigenic effects of cannabinoid (active ingredients found in cannabis) and cannabinoid-like substances in the treatment of neuroblastoma, glioblastoma and other tumors in children including primary cells.
The mechanisms leading to effects of cannabinoid and cannabinoid-like substances, and examining the anti-tumorigenic effects of cannabinoid compounds in in vivo xenograft models.
Publications
A list of publications for Dr. Tamar Fisher is in PubMed. PubMed is a database that includes a listing of scientific articles in the fields of medicine and life sciences.